Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Larson

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Laboratory Animals|September 24, 2024
Simulation methodologies to determine statistical power in laboratory animal research studiesAngela Jeffers, Kathryn Konrad, Gary Larson, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2006
Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitorsShunqi Yan, Todd Appleby, Gary Larson, et al.
Journal of Medical Radiation Sciences|October 15, 2016
Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesiclesSuresh Rana, ChihYao Cheng, Li Zhao, et al.
Journal of Applied Clinical Medical Physics|June 4, 2014
Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapySuresh Rana, ChihYao Cheng, Yuanshui Zheng, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic studyShunqi Yan, Todd Appleby, Gary Larson, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2006
Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structureShunqi Yan, Gary Larson, Jim Z Wu, et al.
Bioorganic Chemistry|December 20, 2005
Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymeraseYili Ding, Jean-Luc Girardet, Kenneth L Smith, et al.
Plos One|January 23, 2018
Relationship between QTL for grain shape, grain weight, test weight, milling yield, and plant height in the spring wheat cross RL4452/'AC Domain'Adrian L Cabral, Mark C Jordan, Gary Larson, et al.
Acta Oncologica (Stockholm, Sweden)|January 17, 2015
Anterior-oriented proton beams for prostate cancer: A multi-institutional experienceJohn J Cuaron, Alexander A Harris, Brian Chon, et al.
Acta Oncologica (Stockholm, Sweden)|December 7, 2019
Minimal acute toxicity from proton beam therapy for major salivary gland cancerMichael Chuong, John Bryant, William Hartsell, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Laboratory Animals|September 24, 2024
Simulation methodologies to determine statistical power in laboratory animal research studiesAngela Jeffers, Kathryn Konrad, Gary Larson, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2006
Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitorsShunqi Yan, Todd Appleby, Gary Larson, et al.
Journal of Medical Radiation Sciences|October 15, 2016
Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesiclesSuresh Rana, ChihYao Cheng, Li Zhao, et al.
Journal of Applied Clinical Medical Physics|June 4, 2014
Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapySuresh Rana, ChihYao Cheng, Yuanshui Zheng, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic studyShunqi Yan, Todd Appleby, Gary Larson, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2006
Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structureShunqi Yan, Gary Larson, Jim Z Wu, et al.
Bioorganic Chemistry|December 20, 2005
Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymeraseYili Ding, Jean-Luc Girardet, Kenneth L Smith, et al.
Plos One|January 23, 2018
Relationship between QTL for grain shape, grain weight, test weight, milling yield, and plant height in the spring wheat cross RL4452/'AC Domain'Adrian L Cabral, Mark C Jordan, Gary Larson, et al.
Acta Oncologica (Stockholm, Sweden)|January 17, 2015
Anterior-oriented proton beams for prostate cancer: A multi-institutional experienceJohn J Cuaron, Alexander A Harris, Brian Chon, et al.
Acta Oncologica (Stockholm, Sweden)|December 7, 2019
Minimal acute toxicity from proton beam therapy for major salivary gland cancerMichael Chuong, John Bryant, William Hartsell, et al.
Pageof 3